ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

KRBP Kiromic BioPharma Inc

0.60
0.00 (0.00%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kiromic BioPharma Inc KRBP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.60 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.60 0.60
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202407:08BWKiromic BioPharma Reports Consistent Favorable Safety,..
19/4/202415:30EDGAR2Form 8-K - Current report
10/4/202415:30EDGAR2Form RW - Registration Withdrawal Request
05/4/202415:30EDGAR2Form 8-K - Current report
02/4/202415:30EDGAR2Form 8-K - Current report
02/4/202407:18BWKiromic BioPharma Reports Favorable Safety, Tolerability,..
21/3/202416:21EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/3/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/3/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/3/202407:08BWEarly Efficacy Results Show Primary Lung Tumor Stabilization..
01/3/202407:08BWKiromic BioPharma Adds Virginia Oncology Associates, PC as..
28/2/202417:30BWKiromic BioPharma to Present at the OTC Markets’ Virtual..
28/2/202415:09GLOBEKiromic BioPharma to Present at the OTC Markets’ Virtual..
14/2/202415:30EDGAR2Form 8-K - Current report
14/2/202407:08BWResults from First Patient in Kiromic BioPharma’s..
29/1/202406:47BWKiromic BioPharma Reports Favorable Early Efficacy Results..
11/1/202415:15EDGAR2Form 8-K - Current report
05/1/202407:08BWKiromic BioPharma Reports Favorable Early Safety and..
14/12/202307:17BW Kiromic BioPharma Announces First Patient Dosed in Phase 1..
09/11/202308:49EDGAR2Form 8-K - Current report
13/9/202315:45EDGAR2Form 8-K - Current report
13/9/202315:35BWKiromic BioPharma Common Stock to Begin Trading on the OTC..
29/8/202315:15EDGAR2Form 8-K - Current report
15/8/202315:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202315:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202311:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/7/202315:50EDGAR2Form 8-K - Current report
25/7/202315:28EDGAR2Form 8-K - Current report
24/7/202314:53EDGAR2Form 8-K - Current report
24/7/202314:00BWKiromic BioPharma Welcomes Two New Directors to its Board
19/7/202315:15EDGAR2Form 8-K - Current report
18/7/202315:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/7/202315:21EDGAR2Form 8-K - Current report
29/6/202315:33EDGAR2Form S-1 - General form for registration of securities under..

Su Consulta Reciente

Delayed Upgrade Clock